These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32056180)

  • 1. Liquid Biopsy for Investigation of Cancer DNA in Esophageal Squamous Cell Carcinoma.
    Smith RA; Lam AK
    Methods Mol Biol; 2020; 2129():203-215. PubMed ID: 32056180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Biopsy: Detection of Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma.
    Lam AK; Hamid FB; Gopalan V
    Methods Mol Biol; 2020; 2129():193-202. PubMed ID: 32056179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Biopsy for Investigation of Cancer DNA in Esophageal Adenocarcinoma: Cell-Free Plasma DNA and Exosome-Associated DNA.
    Smith RA; Lam AK
    Methods Mol Biol; 2018; 1756():187-194. PubMed ID: 29600371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy of oesophageal squamous cell carcinoma: implications in diagnosis, prognosis, and treatment monitoring.
    Hao MJ; Cheng ZY; Gao Y; Xin L; Yu CT; Wang TL; Li ZS; Wang LW
    Scand J Gastroenterol; 2024 Jun; 59(6):698-709. PubMed ID: 38466190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detention and Identification of Cancer Stem Cells in Esophageal Squamous Cell Carcinoma.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():177-191. PubMed ID: 32056178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome Sequencing in Esophageal Squamous Cell Carcinoma.
    Pillai S; Maksemous N; Lam AK
    Methods Mol Biol; 2020; 2129():217-240. PubMed ID: 32056181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis.
    Fan L; Cao Q; Liu J; Zhang J; Li B
    Mol Cancer; 2019 Jan; 18(1):16. PubMed ID: 30674324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA.
    Yuan Z; Wang X; Geng X; Li Y; Tan F; Xue Q; Gao S; He J
    Cancer Genet; 2021 Nov; 258-259():93-100. PubMed ID: 34688997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry for Biomarkers Discovery in Esophageal Squamous Cell Carcinoma.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():259-268. PubMed ID: 32056183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-lncRNA signature in plasma exosomes serves as diagnostic biomarker for esophageal squamous cell carcinoma.
    Jiao Z; Yu A; Rong W; He X; Zen K; Shi M; Wang T
    Aging (Albany NY); 2020 Jun; 12(14):15002-15010. PubMed ID: 32597791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of MicroRNAs in Esophageal Squamous Cell Carcinoma Pathogenesis.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():241-257. PubMed ID: 32056182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates of liquid biopsy in oral cancer and multiomics analysis.
    Zhang X; Li B
    Oral Dis; 2023 Jan; 29(1):51-61. PubMed ID: 34716963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
    Junqueira-Neto S; Batista IA; Costa JL; Melo SA
    Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ-SLC7A5, a potential prognostic circulating biomarker for detection of ESCC.
    Wang Q; Liu H; Liu Z; Yang L; Zhou J; Cao X; Sun H
    Cancer Genet; 2020 Jan; 240():33-39. PubMed ID: 31726270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid Biopsy: General Concepts.
    Poulet G; Massias J; Taly V
    Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Assays of Biological Aggressiveness of Esophageal Squamous Cell Carcinoma.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():161-175. PubMed ID: 32056177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.
    Yang L; Salai A; Sun X; Liu Q; Liu T; Zhang Q; Tuerxun A; Tan Y; Zheng S; Lu X
    J Proteomics; 2022 Aug; 265():104662. PubMed ID: 35728771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
    Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
    Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy.
    Kim EJ; Im HS; Lee J; Cho EH; Kim YH; Kim HR; Kim JH; Park SR
    Curr Probl Cancer; 2021 Jun; 45(3):100685. PubMed ID: 33342577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging cfDNA fragmentomic features in a stacked ensemble model for early detection of esophageal squamous cell carcinoma.
    Jiao Z; Zhang X; Xuan Y; Shi X; Zhang Z; Yu A; Li N; Yang S; He X; Zhao G; Yang R; Chen J; Wu X; Bao H; Wang F; Ren W; Liang H; Chen Q; Wang T
    Cell Rep Med; 2024 Aug; 5(8):101664. PubMed ID: 39089259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.